Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the American Association for Cancer Research, Verily’s Parkinson’s dataset, the ...

The Michael Davis-led Delaware Rock and Roll Hall of Fame rockabilly act The Bullets have a weekly residency at Gallucio's Italian Restaurant in Wilmington on Thursday nights.

NEWARK- QPS Holdings, LLC, a global clinical research organization (CRO) headquartered in Newark, is expanding its presence ...

Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US.

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

Merck is going all-in on domestic drug manufacturing with a $1 billion Delaware facility aimed at dodging Trump-era tariff ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

Merck breaks ground on new $1 billion biologics center of excellence in Wilmington, Delaware: Rahway, New Jersey Wednesday, April 30, 2025, 09:00 Hrs [IST] Merck, known as MSD out ...

The pharmaceutical giant will invest $1 billion in a Delaware plant to manufacture Keytruda, as drugmakers ramp up U.S.